FGL2 and nonpapillary renal cell carcinoma: We found that high FGL2 expression was associated with significantly poorer OS and RFS than low FGL2 expression in patients with early-stage ccRCC (TNM stage, I + II; log-rank test, P < 0.001; Fig. 3E,F).